ARTSENS® Plus is a non-invasive, operator-independent device designed to detect Early Vascular Ageing (EVA) —a critical indicator of cardiovascular risk. It is the only clinically validated device that measures carotid artery stiffness, aortic pulse wave velocity (PWV), and central blood pressur in a single, automated test, completed in just 10 minutes. Using real-time signal processing and AI-driven analysis, ARTSENS® Plus provides highly accurate, reproducible arterial health assessments with minimal user training. It is ideal for (a) Primary Screening – Early detection of vascular dysfunction to enable timely interventions, (b) Vascular Phenotyping – Identifying individuals who benefit from lifestyle vs. pharmacological management and (c) Risk Stratification – Predicting long-term cardiovascular risk based on vascular ageing. 

​

Clinically Proven, Globally Recognized 

• Validated against FDA-approved predicates per international ARTERY society guidelines

• Tested on 5000+ subjects , deployed in 10+ clinical research centers across India, Europe, and the USA

• 35+ patents, 100+ peer-reviewed publications 

• US FDA 510(k) under review, compliant with IEC 60601-1, -2, -37, EMI/EMC, and biocompatibility standards 

​

Clinical Partners: 

       Radboud UMC (Netherlands), AIIMS Delhi, JIPMER Pondicherry, CMC Vellore, Sitapati Hospital, SDM Dharwad, Kotakkal AVS 

 

Industry Partner: VascRisk LLC 

​

Learn more at artsens.tech